Clinical Trial Update: Effects of Intravenous (IV) Citalopram Hydrochloride During Transcranial Magnetic Stimulation in Major Depressive Disorder (MDD) [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial update evaluating intravenous citalopram hydrochloride during transcranial magnetic stimulation in major depressive disorder; the study i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Citalopram hydrochloride (IV) (citalopram hydrochloride)

Snippet

Sponsor: University of California, Los Angeles | Conditions: Major Depressive Disorder | EARLY_Phase 1 | Status: ACTIVE_NOT_RECRUITING